| The role of regulatory T cells in the pathogenesis and treatment of prostate cancer V Karpisheh, SM Mousavi, PN Sheykholeslami, M Fathi, MM Saray, ... Life sciences 284, 119132, 2021 | 40 | 2021 |
| T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer M Fathi, I Pustokhina, SV Kuznetsov, M Khayrullin, M Hojjat‐Farsangi, ... IUBMB life 73 (5), 726-738, 2021 | 31 | 2021 |
| Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells M Fathi, S Bahmanpour, A Barshidi, H Rasouli, FK Kiani, AMS Khesht, ... International immunopharmacology 101, 108288, 2021 | 24 | 2021 |
| The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer Z Kalaei, R Manafi-Farid, B Rashidi, FK Kiani, A Zarei, M Fathi, ... Cell Communication and Signaling 21 (1), 139, 2023 | 10 | 2023 |
| Targeting the CTLA-4/B7 axes in glioblastoma: preclinical evidence and clinical interventions M Fathi, SM Razavi, M Sojoodi, A Ahmadi, F Ebrahimi, A Namdar, ... Expert Opinion on Therapeutic Targets 26 (11), 949-961, 2022 | 8 | 2022 |
| The prognostic and therapeutic potential of HO-1 in leukemia and MDS M Sadeghi, M Fathi, J Gholizadeh Navashenaq, H Mohammadi, ... Cell Communication and Signaling 21 (1), 57, 2023 | 5 | 2023 |
| The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies M Sadeghi, A Khodakarami, A Ahmadi, M Fathi, ... Expert Opinion on Therapeutic Targets 26 (12), 1057-1071, 2023 | 3 | 2023 |
Farhad Jadidi-NiaraghTabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证
